共 50 条
- [1] A phase II study investigating the safety and efficacy of neoadjuvent atezolizumab in muscle invasive bladder cancer (ABACUS)ANNALS OF ONCOLOGY, 2018, 29 : 319 - 319Castellano, D.Duran, I.Rodriguez-Vida, A.Crabb, S. J.van der Heijden, M. S.Font Pous, A.Gravis, G.Anido Herranz, U.Protheroe, A.Ravaud, A.Maillet, D.Mendez-Vidal, M. J.Suarez, C.Lorch, A.Sternberg, C. N.Linch, M.Sarker, S-J.Notta, J.Mousa, K.Powles, T. B.
- [2] phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in non-urothelial, muscle invasive bladder cancer (ABACUS-2)ANNALS OF ONCOLOGY, 2023, 34 : S1201 - S1202Szabados, B. E.Nogueron Martinez, E.Alvarez Marquez, F. J.Castellano Gauna, D. E.Rodriguez-Vida, A.Garcias de Espana, M. C.Hussain, S. A.Alvarez Fernandez, C.Linch, M.Bonfill Abella, T.Goupil, M. GrossKelly, J.Jones, R. J.Crabb, S.Beltran, L.Garonce-Hediger, R.Rakebrandt, N. J.Georgescu, R.Ackerman, C.Powles, T. B.
- [3] A phase II study investigating neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive bladder cancer: Final analysisANNALS OF ONCOLOGY, 2020, 31 : S1319 - S1319Szabados, B. E.Rodriguez-Vida, A.Duran, I.Crabb, S. J.van der Heijden, M. S.Pous, A. FontGravis, G.Herranz, U. AnidoProtheroe, A.Ravaud, A.Maillet, D.Mendez, M. J.Suarez, C.Linch, M.Prendergast, A.Tyson, C.Mousa, K.Castellano, D.Powles, T. B.
- [4] A phase II study of cabozantinib in combination with atezolizumab as neoadjuvant treatment for muscle-invasive bladder cancer (ABATE)ANNALS OF ONCOLOGY, 2020, 31 : S607 - S607Milowsky, M.Davis, N.Fung, C.Johnson, S.Langenstroer, P.Jacobsohn, K.Bylow, K.Kilari, D.
- [5] Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS TrialEUROPEAN UROLOGY ONCOLOGY, 2021, 4 (03): : 456 - 463Szabados, BernadettRodriguez-Vida, AlejoDuran, IgnacioCrabb, Simon J.Van der Heijden, Michiel S.Pous, Albert FontGravis, GwenaelleHerranz, Urbano AnidoProtheroe, AndrewRavaud, AlainMaillet, DenisMendez-Vidal, Maria J.Suarez, CristinaLinch, MarkPrendergast, AaronTyson, CharlotteMousa, KellyCastellano, DanielPowles, Thomas
- [6] Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II TrialJOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (12) : 1312 - +Funt, Samuel A.Lattanzi, MichaelWhiting, KarissaAl-Ahmadie, HikmatQuinlan, ColleenTeo, Min YuenLee, Chung-HanAggen, DavidZimmerman, DanielleMcHugh, DeaglanApollo, ArlynDurdin, Trey D.Truong, HongKamradt, JeffreyKhalil, MagedLash, BradleyOstrovnaya, IrinaMcCoy, Asia S.Hettich, GraceRegazzi, AshleyJihad, MarwahRatna, NehaBoswell, AbigailFrancese, KaitlynYang, YuanquanFolefac, EdmundHerr, Harry W.Donat, S. MachelePietzak, EugeneCha, Eugene K.Donahue, Timothy F.Goh, Alvin C.Huang, William C.Bajorin, Dean F.Iyer, GopaBochner, Bernard H.Balar, Arjun V.Mortazavi, AmirRosenberg, Jonathan E.
- [7] Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancerJOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 330 - 337Meleis, LauraMoore, RussellInman, Brant A.Harrison, Michael R.
- [8] A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancerASIAN JOURNAL OF UROLOGY, 2022, 9 (03) : 318 - 328Dracham, Chinna BabuKumar, NarendraKumar, SantoshElangovan, ArunYadav, Budhi SinghMavuduru, Ravimohan S.Lal, AnupamGupta, Pramod K.Kapoor, Rakesh
- [9] Neoadjuvant accelerated MVAC (AMVAC) in patients with muscle invasive bladder cancer: Results of a multicenter phase II studyJOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Plimack, Elizabeth R.Hoffman-Censits, Jean H.Viterbo, RosaliaGreenberg, Richard EvanChen, DavidLallas, Costas D.Trabulsi, Edouard JohnWong, Yu-NingKutikov, AlexanderLin, JianqingDuncan, GailAdair, BethCione, CharlotteO'Sullivan, ConorKilpatrick, DeborahRoss, Eric A.Boorjian, Stephen A.Uzzo, Robert G.Kelly, William KevinHudes, Gary R.
- [10] Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer.JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Lattanzi, MichaelSolovyov, AlexanderLihm, JayonQuinlan, ColleenWhiting, KarissaLi, HaoAl-Ahmadie, Hikmat A.Teo, Min YuenAggen, David HenryOstrovnaya, IrinaRegazzi, Ashley MarieJihad, MarwahBajorin, Dean F.Balar, Arjun VasantMortazavi, AmirMerghoub, TahaIyer, GopaRosenberg, Jonathan E.Greenbaum, BenjaminFunt, Samuel Aaron